Personalized Cancer Therapy … safety

We are excited to be working with Texas Tech University on the recently funded National Science Foundation grant project entitled, Design of functionally-tested, genomics-informed personalized cancer therapy drug treatment plans.  This project is led by Dr. Ranadip Pal at TTU, with Dr. Keller at cc-TDI as co-investigator. The goal?  Mathematical approaches to combining personalized, synergistic drugs for relapsed cancer… with patient safety in mind.     

Share this post
Share on facebook
Share on google
Share on twitter
Share on linkedin